Member Info for wildbunch

Cannot see where names are being put forward-then read the messages-you will see Dr Dilly's name-don't know who she is then google her and/or ask us or the company-she is the best chance you have of making your 'feet on the ground based on 50 years experience' average down 'investment' work.

Should be those that disagree with HIM insane!

So the Accountant does not like to be bullied but calls those that disagree with them insane! Hypocritical or what?

That's all.

April meeting-highly likely that vote will be yes for them to stay.

So-we have an Accountant of 50 years standing with experience in bio tech and has feet on the ground telling us that we are deluded. He is down a shed load in Summit (so am I) and invested in Val ( so am I) and has made a feet on the ground decision to average down (I have not) thus throwing good money after bad.

He tells us that we can raise questions at the April meeting-by which time new shares will have been issued and it s highly likely that the vote will be YES any way-also does he really think that these 2 will attend either of the meetings being called.

The business model is to take drugs through initial phase(s) and then sell or partner up for phase 3. square this with dear old George saying that he will leave when regulatory approval is achieved.

What will happen when (if) they get their hands on another £300,000 to £500,00-we don't know-because we have not been told. The suggestion by the Accountantthat they may have taken a salary cut but not told us-but ask them at the next meeting-is absurd. Of course they would have told us to bolster their credibility.

The 2018 accounts show remuneration far in excess of the FT web site-know which number I believe.

The only way this company may survive is with Dr Dilly at the helm.

If this a bluff-now is the time to call it-otherwise turn the lights out.

That's all.

Regarding Chrisatrdg. You may not agree with his view (I don't) but he is kosher-I have met with him at Summit meetings.

That's all.

On the back of this consolidation they may raise a few £100k-this will run out in a few months-what will happen in these few months-we don't know because we have not been told. We do know that much of the money raised will go on Director's remuneration. These people had the chance to explain at the last meeting-but did not even show up. They are now putting the same proposal again-still with no explanation about what might happen in the near future. They have to go now and let Dr Dilly have a shot. This is not madness but clear business sense.

On the topic of average down-fine if you think that the market is seriously under valuing a share (eg look at LGEN-way off it's peak-with low P/E and high dividend well covered)-but an AIM bio tech about to run out of cash-with concerns about both it's leaderships and prospects-that is brave! Of course many of us wish we had got out years ago-but I for one feel that the prospectus we were given was not entirely accurate. Still, a bit late now-no use crying over spilt milk-also no use throwing good money after bad.

GLA

That's all.

Chris-read my earlier posts-it is a big NO. This company is finished without fresh leadership-keep the others as advisors if you want-although I am impressed by Dr Dilly. Will change if we get RNS telling us where we are in terms of clinical research for each product and real interest from pharma. Remember their business model is to take products to Phase 2 and then pass the heavy lifting phase 3 to a big pharma to complete. Where is there any evidence that they will be able to do this in next 3 to 4 months when any any new cash raised runs out?

That's all.

Why the vitriol-this bb should be a vehicle for the exchange of ideas-of course they will be influenced by how much people have invested and when.

Read Suzy Dilly's notes-they indicate strongly that she would be prepared to take on the role of CEO.

Unsure where FT numbers came from-certainly not from the Valirx report and accounts on their website.

That's all.

I have instructed my broker to vote no. This is not because I am mad. These 2 are useless for reasons well documented on this board. They have taken no skin in the game but draw big salaries and award themselves bonuses. There is an alternative in the wings. The amount they can raise will disappear in a very few months. If they have positive news-let's have it now. I do have plenty of skin in the game-I believe that I have a slim chance with new leadership and none with the current leadership.

That's all.

This is hopeless. Market cap under £600k-maximum cash raise around £500k. Only enough working capital for 3 months or so-what will they tell us in 3 months that they cannot tell us now. The cash raise will just pay their salaries for a few more months. We have a potential CEO waiting in the wings-chances are this hopeless anyway-let's give it the only shot we have and vote no and get the leadership change that we need.

IT IS OBVIOUS

That's all.

The market cap is less than £700k Assuming that they raise 100% of this what on earth is it going to be spent on. Currently well over £400k pa is spent on the 2 'key players'-the money will run out in say 6 months-that is being generous -at their current spend it will run out quicker-then what-we will be in same position as we are in now-only with massive dilution and the same 2 'key people' in post. This company is doomed without radical action-that means a change of leadership. We may not make it anyway-but this is our best shot. IT IS OBVIOUS!

That's all.

Our best chance is for Dr Dilly to take on CEO role. This deals with the 'key people' issue at stroke. She is very well qualified to do this and her note show that she is up for the challenge. The current 'key people' have shown by their historical behaviour and their current arrogance that they are totally unsuitable to carry on. I shall be voting against the resolution put before us again and for them to be sacked.

These 'key players' have destroyed shareholder value while awarding themselves handsome salaries and bonuses. Their information to shareholders has been at best derisory and at worst mis-leading-their commitment has not extended to investing their own money-'mortgages to pay' for heaven's sake-or even attending the recent meeting about the consolidation. The current management of this company has run it's course-to continue with it will doom it to certain failure-the only hope is something else. Good luck and thank you to the shareholder action group.

That's all.

Sorry typos. known not know. Cash not can.

So-Duggan gets 75% of company at a low market price. Cash runway to January 2021 when results of phase 3 still not know-so more can needed then. Edwards looked after-now Chairman. Huge dilution and more to come. Nothing at all like Immupharma.

Just a whinge.

That's all.

Imm is funded for phase 3-with more deals in the pipeline.

Summit runs out of money in January ish 2020. They have a shareholder that owns 48% of the company which he bought for about 20pish a share. He could easily buy the whole lot for around 30p per share. Summit have potentially a great drug but are running out of time and money. Easy-there is no 'possibly' about them running out of money-that are-and the CEO says that they are. The current share price reflects that fact. Clearly this will change if money arrives-best case non-dilutive-next best dilutive-worst case takeover at around 30p.

Sad but true.

That's all.

What about the 200,000+ sell?

Chris, The CEO would be 'chippy' if Duggan had told him if necessary he would buy it all and look after him with some sort of bonus equivalent to his share option arrangement.

Why do you post year after year. Yo cannot be a holder-so why the big interest?